Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

VLDLR Antibody (04), PE, Novus Biologicals™
SDP

Catalog No. NB351163 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB351163 0.1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NB351163 Supplier Novus Biologicals Supplier No. NBP306596PE
Add to Cart
Add to Cart

Mouse Monoclonal Antibody

VLDLR Monoclonal antibody specifically detects VLDLR in Human samples. It is validated for ELISA

Specifications

Antigen VLDLR
Applications ELISA
Classification Monoclonal
Clone 04
Conjugate PE
Dilution ELISA
Formulation PBS
Gene Alias CARMQ1, CHRMQ1, FLJ35024, very low density lipoprotein receptor, very low-density lipoprotein receptor, VLDL receptor, VLDL-R, VLDLRCH
Host Species Mouse
Immunogen This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human VLDLR (Accession#: NP_003374.3; Met 1-Ser 797).
Purification Method Protein A purified
Quantity 0.1 mL
Regulatory Status RUO
Research Discipline Apoptosis, Cholesterol Metabolism, Lipid and Metabolism, Neurodegeneration, Neuronal Cell Markers, Neuroscience
Primary or Secondary Primary
Gene ID (Entrez) 7436
Target Species Human
Content And Storage Store at 4C in the dark.
Form Purified
Isotype IgG1
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.